血栓通注射液联合依达拉奉治疗急性脑梗死的临床观察

目的：观察依达拉奉联合血栓通注射液治疗急性脑梗死的临床效果。方法：将90例急性脑梗死患者随机分为对照组和观察组，每组各45例。对照组在常规治疗的基础上给予血栓通注射液，观察组在对照组治疗基础上加用依达拉奉，疗程14天。比较两组患者治疗后的临床效果及治疗后14天和21天的神经功能缺失评分。结果：治疗14天后观察组总有效率明显高于对照组，差异有统计学意义（91.1% vs 75.6%，P＜0.05）；治疗后14天及21天观察组神经功能缺失评分明显小于对照组，差异均有统计学意义（P＜0.05）。结论：依达拉奉联合血栓注射液通治疗急性脑梗死临床效果确切，值得推广应用。

The clinical observation of treating acute cerebral infarction with Xueshuantong injection and edaravone

Objective：To observe the clinical efficacy of Xueshuantong injection and edaravone on treating acute cerebral infarction . Methods：90 patients with acute cerebral infarction were divided into control group（n=45） and observation group（n=45） equally. Patients in the con trol grou p were given X ueshuantong injection based on conventional therapy, while patien ts in the obser vation group were given edaravone on the basis of treatment for the control group. The treatment period was fourteen days. The clinical efficacy and neural function loss score of the two groups were compared 14 and 21 days after the treatment. Results：14 days after the treatment, the total effective rate of the observation group was apparently high er than that of the control group and the dif ference was statistically sign ificant （91.1%vs 75.6%,P〈0.05）;14 and 21 days after the treatment, the nerve function loss score of the observation group were obviously lower than that of th e control group and th e difference was statistically sign ificant（P〈0.05）.Conclusion：Edaravon e combined with Xueshuantong injection works well in the treatment of acute cerebral infarction. The curative efficacy was precise. So it is worthy of being promoted.